Skip to main content

Market Overview

Benzinga Pro's 5 Stocks To Watch Today

Share:

Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!

Enphase Energy Inc (NASDAQ: ENPH) stock was trading higher by more than 30 percent early Wednesday morning in reaction to an acquisition announcement. The global energy technology company agreed to acquire SunPower Corporation (NASDAQ: SPWR)'s microinverter business for $25 million in cash and 7.5 million shares of Enphase common stock. The transaction also adds 140 new patents to Enphase's IP portfolio.

Sprint Corp (NYSE: S) was trading higher by more than 2 percent, likely in reaction to Tuesday's court decision that favors AT&T Inc. (NYSE: T)'s acquisition of Time Warner Inc (NYSE: TWX). According to Fierce Wireless, Tuesday's merger ruling could be seen as a "positive sign" for Sprint's potential merger with T-Mobile Us Inc (NASDAQ: TMUS).

WSI Industries, Inc. (NASDAQ: WSCI) was trading higher by more than 10 percent in reaction to a top-and-bottom-line earnings beat. The company reported it made 16 cents per share in the fiscal third quarter on revenue of $9.79 million versus expectations of a 6-cent per share loss and $9.594 million.

Sharing Economy International Inc (NASDAQ: SEII) was trading higher by more than 20 percent. The China-based company that targets the global sharing economy markets said one of its wholly-owned subsidiary entered into a licensing agreement with Ecrent Capital to establish a website platform in North Korea.

Can Fite Biofarma Ltd (NYSE: CANF) was trading higher by nearly 20 percent. Analysts at H.C. Wainwright initiated coverage of the biotechnology company that treats inflammatory and liver diseases with a Buy rating and $8 price target, which implies notable upside from Tuesday's closing price of $1.30.

Related Links:

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111

 

Related Articles (CANF + ENPH)

View Comments and Join the Discussion!

Posted-In: News Pre-Market Outlook Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com